[11C] (R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis

Neurology

Volumn 53, Issue 9, 1999, Pages 2199-2203

  Banati, Richard B ^c   Goerres, G W ^d   Myers, R ^d   Gunn, R N ^d   Turkheimer, F E ^d   Kreutzberg, G W ^b   Brooks, D J ^d   Jones, T ^d   Duncan, J S ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d NONE

Author keywords

Epilepsy; Mesial temporal sclerosis; Mitochondrial benzodiazepine receptor; Peripheral benzodiazepine receptor

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBON 11; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; ISOQUINOLINE DERIVATIVE;

ARTICLE; BRAIN MAPPING; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENCEPHALITIS; HEMISPHERECTOMY; HIPPOCAMPUS; HUMAN; MICROGLIA; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RASMUSSEN SYNDROME; ADOLESCENT; ADULT; BRAIN; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEASIBILITY STUDY; FEMALE; FOCAL EPILEPSY; IMMUNOLOGY; MACROPHAGE; MALE; MIDDLE AGED; SCINTISCANNING; SCLEROSIS; TEMPORAL LOBE EPILEPSY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BRAIN; BRAIN MAPPING; DIAGNOSIS, DIFFERENTIAL; ENCEPHALITIS; EPILEPSIES, PARTIAL; EPILEPSY, COMPLEX PARTIAL; FEASIBILITY STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; ISOQUINOLINES; MACROPHAGES; MALE; MICROGLIA; MIDDLE AGED; SCLEROSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032585663     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.9.2199     Document Type: Article

References (13)

1. Oguni H, Andermann F, Rasmussen TB. The syndrome of chronic encephalitis and epilepsy. A study based on the MNI series of 48 cases. Adv Neurol 1992;57:419-433.
2. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-318.
3. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW. Cytotoxicity of microglia. Glia 1993;7:111-118.
4. 3H]PK11195 binding to activated microglia. J Neurocytol 1997;26:77-82.
5. Ramsay SC, Weiller C, Myers R, et al. Monitoring by PET of macrophage accumulation in brain after ischaemic stroke. Lancet 1992;339:1054-1055.
6. Banati RB, Goerres G, Perkin D, et al. Imaging microglial activation in vivo. J Cereb Blood Flow Metab 1997;17(suppl 1):435.
7. 11C](R)-PK11195 to image focal and regional brain pathology. In: Carson RE, Daube-Witherspoon ME, Herscovitch P, eds. Quantitative functional brain imaging with positron emission tomography. London: Academic Press, 1997:195-200.
8. Graeber MB, Bise K, Mehraein P. CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. Neuropathol Appl Neurobiol 1994;20:406-408.
9. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 1997;6:279-287.
10. Benavides J, Cornu P, Dennis T, et al. Imaging of human brain lesions with an omega 3 site radioligand. Ann Neurol 1988;24:708-712.
11. Studholme C, Hill DLG, Hawkes DJ. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Physiol 1997;24: 25-35.
12. Rey JJ. Introduction to robust and quasi-robust statistical methods. Berlin: Springer-Verlag, 1983:124-130.
13. 3H]PK11195 binding in relation to imidazoline-12-receptor and alpha 2-adrenoceptor binding in the hippocampus following transient global forebrain ischaemia in the rat. Neuroscience 1998;82:805-817.